Report cover image

Analgesics in Latvia

Published Oct 02, 2025
Length 21 Pages
SKU # EP20463775

Description

Analgesics is expected to register positive current value growth in Latvia in 2025. Performance was driven by strong gains in single ingredient systemic products, notably adult ibuprofen, which is expected to register the highest value growth, along with paediatric ibuprofen, ketoprofen and acetaminophen and also to a lesser extent topical analgesics. On the other hand, adult aspirin and adult combination analgesics is expected to see value sales fall. Global brands are working on increasing foo...

Euromonitor International's Analgesics in Latvia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2020-2024, allowing you to identify the sectors driving growth. Forecasts to 2029 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Table of Contents

21 Pages
Analgesics in Latvia
Euromonitor International
October 2025
List Of Contents And Tables
ANALGESICS IN LATVIA
KEY DATA FINDINGS
2025 DEVELOPMENTS
Ibuprofen best performer in 2025
Mepha benefits from increasing popularity of topical analgesics
Pharmacies hold a monopoly
PROSPECTS AND OPPORTUNITIES
Slight fall in constant value sales
Increasing demand for more natural offerings
Focus on improving communications, as well as adopting a greener positioning
CATEGORY DATA
Table 1 Sales of Analgesics by Category: Value 2020-2025
Table 2 Sales of Analgesics by Category: % Value Growth 2020-2025
Table 3 NBO Company Shares of Analgesics: % Value 2021-2025
Table 4 LBN Brand Shares of Analgesics: % Value 2022-2025
Table 5 Forecast Sales of Analgesics by Category: Value 2025-2030
Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2025-2030
CONSUMER HEALTH IN LATVIA
EXECUTIVE SUMMARY
Consumer Health in 2025: The big picture
Key trends in 2025
Competitive landscape
Channel developments
What next for consumer health?
MARKET INDICATORS
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2020-2025
Table 8 Life Expectancy at Birth 2020-2025
MARKET DATA
Table 9 Sales of Consumer Health by Category: Value 2020-2025
Table 10 Sales of Consumer Health by Category: % Value Growth 2020-2025
Table 11 NBO Company Shares of Consumer Health: % Value 2021-2025
Table 12 LBN Brand Shares of Consumer Health: % Value 2022-2025
Table 13 Penetration of Private Label by Category: % Value 2020-2025
Table 14 Distribution of Consumer Health by Format: % Value 2020-2025
Table 15 Distribution of Consumer Health by Format and Category: % Value 2025
Table 16 Forecast Sales of Consumer Health by Category: Value 2025-2030
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2025-2030
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
SOURCES
Summary 1 Research Sources

Search Inside Report

How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.